Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 6:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 133 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Bariatric Surgery Patients Clear all

Conditions: Lisdexamfetamine
Interventions: Lisdexamfetamine; Drug
Lead sponsor: North Dakota State University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Fargo, North Dakota

Conditions: Obesity, Vitamin D Deficiency
Interventions: Vitamin D3 and Calcium; Dietary Supplement
Lead sponsor: Vadim Sherman, MD; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Diabetes Mellitus, Type 2, Obesity
Interventions: Laparoscopic sleeve gastrectomy, Intensive medical management; Procedure · Behavioral
Lead sponsor: 59th Medical Wing; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Obesity, Morbid, Surgery, Bariatric Surgery Candidate
Interventions: Neurontin, Dilaudid Injectable Product, Marcaine Injectable Product, Oxycodone Hydrochloride, Hycet 7.5Mg-325Mg/15Ml Solution, Zofran Injection, Scopolamine patch, Ativan, Flexeril Oral Product, Tylenol Suspension; Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 35 Years to 65 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Obesity, Morbid
Interventions: Reimagining Us in the Context of Bariatric Surgery (ReConnect); Behavioral
Lead sponsor: Larissa McGarrity, Ph.D.; Other
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Obesity
Interventions: Acceptance and Commitment Therapy-Based Physical Activity Intervention, Physical Activity Education Control; Behavioral
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years to 64 Years
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Sedentary Behavior
Interventions: Behavioral intervention to reduce sedentary time delivered via mobile smartphone; Behavioral
Lead sponsor: The Miriam Hospital; Other
Eligibility: 21 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Morbid Obesity
Interventions: Gastric Plication; Procedure
Lead sponsor: Ethicon Endo-Surgery; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 2
States / cities: Cleveland, Ohio • Columbus, Ohio

Conditions: Severe Obesity, Hypoxia
Interventions: Non-invasive positive pressure ventilation through nasal mask, Rescue non-invasive positive pressure ventilation through nasal mask, Secondary rescue maneuvers; Device · Other
Lead sponsor: Bristol Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Bristol, Connecticut

Conditions: Obesity
Interventions: Not listed
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Diabetes Mellitus, Type 2, Obesity
Interventions: canagliflozin, Placebo (for canagliflozin); Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 20 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Postoperative Nausea and Vomiting, Respiratory Conditions Due to Other External Agents
Interventions: Sugammadex, Neostigmine; Drug
Lead sponsor: Virtua Health, Inc.; Other
Eligibility: 18 Years to 85 Years
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Mount Holly, New Jersey

Conditions: Nausea, Postoperative, Vomiting, Postoperative
Interventions: nausea relief inhaler; Other
Lead sponsor: Methodist Health System; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Mansfield, Texas

Conditions: Post Bariatric Hypoglycemia
Interventions: Lyo avexitide, Liq avexitide; Drug
Lead sponsor: Tracey McLaughlin; Other
Eligibility: 18 Years to 70 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pain
Interventions: Dexmedetomidine, Normal Saline; Drug
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Obesity
Interventions: Not listed
Lead sponsor: Ascension St. Vincent Carmel Hospital; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Carmel, Indiana

Conditions: Obesity, Morbid
Interventions: maintenance intervention; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Morbid Obesity, Bariatric Surgery Patient
Interventions: Not listed
Lead sponsor: Oregon Weight Loss Surgery, LLC; Other
Eligibility: 18 Years to 69 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2024
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Obesity, Morbid, Postoperative Pain, Postoperative Nausea and Vomiting
Interventions: Gabapentin, Placebo; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 80 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Obesity, Obesity, Morbid, Obese, GI Disorders, Gastrointestinal Diseases
Interventions: Transnasal Endoscopy, Esophagogastroduodenoscopy; Device · Procedure
Lead sponsor: Christopher C. Thompson, MD, MSc; Other
Eligibility: 18 Years to 90 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Bariatric Surgery, Transverse Abdominal Plane Regional Blocks
Interventions: Transverse abdominal plane block, Ropivacaine; Procedure · Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Breast Cancer, Morbid Obesity, Bariatric Surgery Candidate
Interventions: Bariatric surgery; Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 40 Years to 74 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Weston, Florida

Conditions: Morbid Obesity, Weight Reduction
Interventions: Decider Guider: Weight Loss; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Nausea, Postoperative
Interventions: QUEASEEase aromatherapy quick tab, Placebo product; Other
Lead sponsor: Inova Health Care Services; Other
Eligibility: 18 Years to 99 Years
Enrollment: 113 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Fairfax, Virginia

Search by objective public record fields.

Pharmacokinetics of Lisdexamfetamine (Vyvanse®) in Post-bariatric Surgery Patients

Efficacy of Vitamin D Supplementation in Bariatric Surgery Patients

Sleeve Gastrectomy Versus Medical Management for Remission of Diabetes in Mild to Moderately Obese Patients

Multimodal Analgesia Effect on Post Surgical Patient

Positive Psychology Intervention for Patients Post-bariatric Surgery and Their Partners

Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery

Reducing Sedentary Time in Obese Adults

Surgical Intervention in Bariatric Patients: Excess Weight Loss in the Morbidly Obese Following Gastric Plication

Use of Non-Invasive Positive Pressure Ventilation in Patients With Severe Obesity Undergoing Upper Endoscopy Procedures

Protocol for the Assessment of Variability in Histology and Gene Expression in Bariatric Surgery Patients.

CARAT: Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes

A Study to Compare Neostigmine vs Sugammadex in Length of PACU Stay in Patients Undergoing Sleeve Gastrectomy Surgery

Decreasing Post-Operative Nausea and Vomiting in the Bariatric Surgical Patient

Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia

Evaluation of Dexmedetomidine on Post-operative Narcotic Requirements and Pain Scores in Bariatric Patients

Prophylactic Enoxaparin Dosing in Roux-en-Y Gastric Bypass Surgery Patients at St. Vincent Carmel

Development of a Weight Maintenance Intervention for Bariatric Surgery Patients

Appetite Suppression / Hormone Study Control Group

Study of the Effect of the Drug Gabapentin on Postoperative Pain and Incidence of Postoperative Nausea and Vomiting

Trans-nasal Endoscopy for Bariatric Patients

Regional TAP Block for Bariatric Patients

Effects of Bariatric Surgery on Breast Density Improvement and Impact on Breast Cancer Risk in Severe Obese Patients

Improving Patient Decisions About Bariatric Surgery

Effects of Aromatherapy on Nausea Levels